Zoetis Inc.
73.31USD
-0.2500 (-0.34%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.51▼ | $1.85 | 0 | 13 |
| Next quarter | $1.3▼ | $1.65 | 0 | 13 |
| Current year | $6.21▼ | $6.91 | 0 | 15 |
| Next year | $6.53▼ | $7.42 | 0 | 15 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.85 | $1.87 | +0.02 (+1.0%) |
| 2026-03-31 | $1.62 | $1.53 | -0.09 (-5.3%) |
| 2025-12-31 | $1.4 | $1.48 | +0.08 (+5.5%) |
| 2025-09-30 | $1.62 | $1.7 | +0.08 (+4.8%) |
230 ratings from 34 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | $104 $94 | Aug 25, 2026 |
| Stifel | Maintained | Hold | $85 $80 | Aug 20, 2026 |
| Citigroup | Maintained | Buy | $112 $96 | Aug 11, 2026 |
| BNP Paribas | Maintained | Outperform | $146 $110 | Aug 11, 2026 |
| Piper Sandler | Maintained | Neutral | $90 $80 | Aug 10, 2026 |
| UBS | Maintained | Neutral | $85 $80 | Aug 7, 2026 |
| JP Morgan | Maintained | Overweight | $130 $115 | Aug 7, 2026 |
| William Blair | Downgraded from Outperform | Market Perform | — | Aug 6, 2026 |
| UBS | Maintained | Neutral | $99 $85 | Jul 27, 2026 |
| Morgan Stanley | Maintained | Overweight | $115 $99 | Jul 22, 2026 |
| HSBC | Maintained | Buy | $140 $95 | Jul 6, 2026 |
| Barclays | Maintained | Equal-Weight | $136 $85 | Jul 1, 2026 |
| TD Cowen | Maintained | Buy | $150 $104 | Jun 30, 2026 |
| Stifel | Maintained | Hold | $95 $85 | Jun 26, 2026 |
| Argus Research | Downgraded from Buy | Hold | — | May 27, 2026 |
| Stifel | Maintained | Hold | $105 $95 | May 22, 2026 |
| Citigroup | Maintained | Buy | $145 $112 | May 18, 2026 |
| UBS | Maintained | Neutral | $130 $99 | May 8, 2026 |
| JP Morgan | Maintained | Overweight | $190 $130 | May 8, 2026 |
| UBS | Maintained | Neutral | $136 $130 | Apr 28, 2026 |
| Citigroup | Initiated | Buy | $145 | Apr 15, 2026 |
| B of A Securities | Maintained | Neutral | $135 $140 | Feb 13, 2026 |
| Piper Sandler | Downgraded from Overweight | Neutral | $190 $135 | Jan 22, 2026 |
| Barclays | Initiated | Equal-Weight | $136 | Dec 9, 2025 |
| BTIG | Reiterated | Buy | $160 | Dec 3, 2025 |
93 filings from 24 insiders · 0 buy / 0 sell over 6m
Officers and directors of ZTS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| SACCARO JAMESOfficer, EVP, CFO & COO | GrantRestricted Stock Unit | 81.1k | — | — | Aug 31, 2026 |
| D AMELIO FRANK ADirector | Gift | 6.7k | — | — | Aug 7, 2026 |
| MCCALLISTER MICHAEL BDirector | Gift | 1.2k | — | — | Jun 10, 2026 |
| STETTER MARKDirector | Other | 1.6k | — | — | May 21, 2026 |
| PARENT LOUISE MDirector | Other | 12.1k | — | — | May 20, 2026 |
| D AMELIO FRANK ADirector | Buy | 6.7k | $75.39 | $501k | May 13, 2026 |
| BISARO PAUL M.Director | Buy | 2.0k | $75.88 | $152k | May 13, 2026 |
| MCCALLISTER MICHAEL BDirector | Buyindirect | 3.0k | $77.76 | $233k | May 11, 2026 |
| ESCH KEVIN PH.D.Officer | Other | 259 | — | — | Apr 30, 2026 |
| SARBAUGH KEITHOfficer | Other | 1.5k | — | — | Mar 31, 2026 |
| NORDEN GREGORYDirector | Gift | 1.2k | — | — | Mar 9, 2026 |
| BROADHURST VANESSADirector | Other | 1.6k | — | — | Feb 19, 2026 |
| FERRAN ASTORGA JEANNETTEOfficer | Other | 431 | — | — | Feb 19, 2026 |
| FULLER JULIEOfficer | Other | 750 | — | — | Feb 19, 2026 |
| LEATHERBERRY ANTOINETTE RENEEDirector | Other | 1.6k | — | — | Feb 19, 2026 |
| ESCH KEVIN PH.D.Officer | Other | 102 | — | — | Feb 19, 2026 |
| SARBAUGH KEITHOfficer | Other | 386 | — | — | Feb 19, 2026 |
| DRISCOLL RIMMAOfficer | Other | 454 | — | — | Feb 19, 2026 |
| ASHTON NICHOLASOfficer | Other | 750 | — | — | Feb 19, 2026 |
| LAGANO ROXANNEOfficer | Other | 750 | — | — | Feb 19, 2026 |
No analyst notes on ZTS yet.
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 5 | 9 | 0 | 0 | Buy2.28 |
| 1 mo ago | 4 | 5 | 9 | 0 | 0 | Buy2.28 |
| 2 mo ago | 3 | 8 | 9 | 0 | 0 | Buy2.30 |
| 3 mo ago | 3 | 8 | 9 | 0 | 0 | Buy2.30 |